Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo deletions and duplications of 17q25.3 cause susceptibility to cardiovascular malformations.

Orphanet journal of rare diseases·2015
Same author

Olfactory copy number association with age at onset of Alzheimer disease.

Neurology·2011
Same author

20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits.

Journal of medical genetics·2008
Same author

Amerindian ancestry in Argentina is associated with increased risk for systemic lupus erythematosus.

Genes and immunity·2008
Same author

Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells.

Cell proliferation·2008
Same author

Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans.

American journal of human genetics·2007

Related Experiment Video

Updated: May 3, 2026

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

11.3K

Methods for efficient retrovirus-mediated gene transfer to mouse hematopoietic stem cells.

J W Belmont1, R Jurecic

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.

Methods in Molecular Medicine
|February 5, 2014
PubMed
Summary

Gene therapy using hematopoietic stem cells (HSC) shows promise for treating diseases. Research in mouse models advances understanding of gene transfer into HSC, but challenges remain for human applications.

More Related Videos

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages
09:07

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages

Published on: October 30, 2018

10.1K
Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice
09:08

Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice

Published on: July 11, 2016

8.8K

Related Experiment Videos

Last Updated: May 3, 2026

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

11.3K
Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages
09:07

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages

Published on: October 30, 2018

10.1K
Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice
09:08

Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice

Published on: July 11, 2016

8.8K

Area of Science:

  • Hematology
  • Gene Therapy
  • Stem Cell Biology

Background:

  • Genetic and acquired diseases may be treated by gene therapy targeting hematopoietic stem cells (HSC).
  • Developing reliable gene transfer methods into stem cells necessitates understanding their biology and role in hematopoiesis.
  • Research in stem cell biology and gene therapy is converging.

Purpose of the Study:

  • To review the principles and factors involved in efficient gene transfer into hematopoietic stem cells.
  • To discuss the utility of murine models in advancing stem cell transduction research.
  • To highlight challenges and future directions for clinical applications of HSC gene therapy.

Main Methods:

  • Utilizing murine models to establish principles of retroviral vector transduction in hematopoietic stem cells.
  • Identifying key factors influencing efficient stem cell transduction in mouse models.
  • Comparing the efficacy of gene transfer methods across different species, including mice, dogs, nonhuman primates, and humans.

Main Results:

  • Retroviral vectors can transduce self-renewing hematopoietic stem cells and express foreign genes in their progeny.
  • Murine models have identified crucial factors for efficient stem cell transduction.
  • Gene transfer methods effective in mice show limited success in other species, including humans.

Conclusions:

  • Murine models are valuable for understanding hematopoietic stem cell gene transfer mechanisms.
  • Translating successful mouse protocols to human applications requires addressing species-specific differences and technical challenges.
  • Further research using mouse models can inform the development of enhanced and reproducible gene transfer protocols for clinical use.